Cowealth Medical China Co.Ltd. (SHG:603122) — Market Cap & Net Worth
Market Cap & Net Worth: Cowealth Medical China Co.Ltd. (603122)
Cowealth Medical China Co.Ltd. (SHG:603122) has a market capitalization of $809.64 Million (CN¥5.53 Billion) as of September 24, 2026. Listed on the SHG stock exchange, this China-based company holds position #9999 globally and #2655 in its home market, demonstrating a 14.97% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cowealth Medical China Co.Ltd.'s stock price CN¥13.90 by its total outstanding shares 398052633 (398.05 Million). Also see Cowealth Medical China Co.Ltd. asset portfolio for a full breakdown of the balance sheet.
Cowealth Medical China Co.Ltd. Market Cap History: 2022 to 2026
Cowealth Medical China Co.Ltd.'s market capitalization history from 2022 to 2026. Data shows growth from $633.23 Million to $809.64 Million (21.06% CAGR). Also see cash efficiency ratio of Cowealth Medical China Co.Ltd. for how efficiently the company converts equity into cash flow.
Cowealth Medical China Co.Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cowealth Medical China Co.Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Cowealth Medical China Co.Ltd. stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
2.10x
Cowealth Medical China Co.Ltd.'s market cap is 2.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $633.23 Million | $1.28 Billion | $82.72 Million | 0.49x | 7.66x |
| 2023 | $463.56 Million | $1.09 Billion | $47.19 Million | 0.42x | 9.82x |
| 2024 | $408.32 Million | $939.14 Million | $27.57 Million | 0.43x | 14.81x |
| 2025 | $1.42 Billion | $677.79 Million | -$33.64 Million | 2.10x | N/A |
Competitor Companies of 603122 by Market Capitalization
Companies near Cowealth Medical China Co.Ltd. in the global market cap rankings as of September 24, 2026. Review tangible net worth ratio of Cowealth Medical China Co.Ltd. to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Cowealth Medical China Co.Ltd. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #155 globally with a market cap of $156.17 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #456 globally with a market cap of $60.75 Billion USD ( CN¥415.14 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #581 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $658.52 |
| #155 | Danaher Corporation | NYSE:DHR | $156.17 Billion | $221.09 |
| #456 | WuXi AppTec Co Ltd | SHG:603259 | $60.75 Billion | CN¥167.85 |
| #581 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $390.90 |
Cowealth Medical China Co.Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Cowealth Medical China Co.Ltd.'s market cap moved from $633.23 Million to $ 809.64 Million, with a yearly change of 21.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥809.64 Million | -43.03% |
| 2025 | CN¥1.42 Billion | +248.07% |
| 2024 | CN¥408.32 Million | -11.92% |
| 2023 | CN¥463.56 Million | -26.79% |
| 2022 | CN¥633.23 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Cowealth Medical China Co.Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $809.64 Million USD |
| MoneyControl | $809.64 Million USD |
| MarketWatch | $809.64 Million USD |
| marketcap.company | $809.64 Million USD |
| Reuters | $809.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Cowealth Medical China Co.Ltd.
Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company w… Read more